SunTech
BlinkTech Technology

BlinkTech Technology

How BlinkTech tablets are made

Formulation and freeze-drying create the porous tablet. Protective packaging helps keep it stable.

Rapid disintegration in water: a freeze-dried tablet is added, begins disintegrating and disperses, alongside a comparison tablet. Demonstration photographs on a continuous black background.

Rapid disintegration in water

Freeze-dried tablet demonstration

1. Tablet added2. Disintegration begins3. Tablet disperses4. End of demonstrationComparison tablet

1. Tablet added → 2. Disintegration begins → 3. Tablet disperses → 4. End of demonstration. Comparison tablet shown at right.

Technology overview

See how a freeze-dried tablet is made

Follow a formulation through filling, freezing, drying and protective packaging. The full film includes English narration and captions.

How BlinkTech freeze-dried tablets are made
Play full film
Silent preview

See the format in motion

BlinkTech tablets break apart in saliva or water

Animated demonstration of freeze-dried tablets
The tablet format
Animated demonstration of a tablet disintegrating in water
Disintegration in water
How freeze-drying creates a porous tabletA prepared formulation is frozen. Ice is removed as vapor under vacuum, leaving pores in the tablet. Conceptual illustration, not a microscopic image.Prepared formulationFrozen structurePorous tabletMix & fillRapidly freezeRemove ice under vacuum
  1. Mix & fill

    Prepare the formulation and fill individual doses.

  2. Rapidly freeze

    Form ice crystals within the prepared formulation.

  3. Vacuum dry

    Remove ice as vapor, leaving a porous tablet.

Freeze-drying removes ice through sublimation and leaves a porous structure.

How freeze-drying creates the tablet

The formulation is filled into individual doses and frozen. Drying under vacuum removes the ice as vapor, leaving tiny channels. Saliva can enter these channels and help the tablet break apart. This is called disintegration.

Freeze-drying is also called lyophilization. The ingredients that hold the tablet together form its matrix.

What the platform can do

Formulations beyond probiotics

BlinkTech can be used to develop nutrition, pharmaceutical and veterinary formulations. Each project starts with the ingredient, dose, intended user and the evidence needed for that use.

BlinkTech offers a development pathway for a broad range of medicines currently taken as tablets or capsules. Suitability is assessed ingredient by ingredient, including dose, stability, taste and the required release profile.

NutritionLive cultures, vitamins and other ingredient combinations
Pharmaceutical developmentOral dosage forms for your product
Veterinary applicationsFormats developed around the intended species and use

Each opportunity starts with feasibility and supporting data. Probiotic survival, retained activity and storage life must be established for the finished formulation and its packaging.

Discuss your formulation →

Formulation science

Tablet structure, taste and dosing

Development brings together tablet structure, ingredient distribution and controlled freezing and drying.

1

Tablet structure and taste

Choose supporting ingredients (excipients) that hold the tablet together and help manage taste and mouthfeel.

2

Even ingredient distribution and consistent dosing

Prepare and mix ingredients evenly, then fill a measured amount into each cavity.

3

Freezing, drying and production scale

Set cooling and drying conditions that balance rapid breakup, handling strength and stability.

Original porous tablet matrix image from the BlinkTech technical presentation
Tablet matrix at 2,000×, as labeled in the technical presentation. This image illustrates structure; it is not evidence of absorption or clinical performance.

How does a laboratory sample become a production batch?

A tablet needs enough structure to survive filling, drying, sealing and opening. Formulation work includes choosing the ingredients that hold the tablet together, adjusting taste and setting the cooling and drying rates.

In its 2024 technical presentation, the manufacturer describes more than ten years of work on freezing profiles and reports modifying over 80% of its equipment. For a proposed transfer, request the trial batch size, critical settings, sampling plan, yield definition and the results that will qualify the receiving line.

Why does the tablet break up so quickly?

As ice leaves the frozen tablet during vacuum drying, it leaves small channels in the ingredients that hold the tablet together. Saliva can enter these channels and wet the water-soluble material throughout the tablet. Formulation teams adjust this structure to balance rapid breakup with enough strength to handle the tablet.

The process described in the technical presentation uses liquid nitrogen, a coolant at about −196 °C. To assess a specific product, ask for its measured temperature during freezing and drying, the cooling rate and the performance of the finished tablet.

Dosage form comparison

Compressed ODTPowder compacted into a tablet
Freeze-dried tabletPores left after ice is removed
Comparison of compressed and freeze-dried tablet formats
Compressed orally disintegrating tabletsVSFreeze-dried fast-release tablets
Varies by formulationDisintegration timeRapid breakup; reported reference: under 4 seconds
Confirmed by product testingImpurity contentConfirmed by product testing
The tablets vary in size and are generally largerDosage weight and sizeThe porous format can produce a light tablet. Ask for measured tablet weights for your batch.
Depends on the formulationExcipient drug ratioOptions with fewer excipients. The ratio varies.
Depends on the ingredients selectedExcipient solubilityMatrix ingredients that dissolve in water
Varies by productBioavailabilityVaries by product. Any improvement requires evidence.
Varies by productAbsorption rateVaries by product. Rapid breakup alone does not establish absorption.

Swipe across the table to compare both formats.

Detailed science and supporting evidence

Manufacturing approaches differ; measured performance depends on the finished formulation. Claims about purity, absorption or treatment outcomes require evidence for the specific product. On small screens, swipe across this detailed table.

Technical considerations, feature by feature
Compressed ODTComparisonFreeze-dried tablet
A powder blend is compressed into a solid tablet.How it is formedA formulation is frozen and dried under vacuum to create a porous matrix.
Particle size, excipients and taste masking shape the experience.MouthfeelThe porous matrix breaks apart in saliva. Smoothness and taste depend on the formulation.
Can be rapid; the time depends on the product and test method.Disintegration timeDesigned for rapid breakup. A technical presentation reports an example that took four seconds. Confirm the specification for your formulation.
Measure how quickly the ingredient dissolves using an appropriate test.Dissolution rateRapid breakup exposes the matrix to fluid; the ingredient’s dissolution rate still needs testing.
Compare release profiles and consistency across the tested units.Dissolution uniformityCompare release profiles and consistency using the same method and sampling plan.
Established through analytical testing and stability studies.Impurity contentEstablished through analytical testing and stability studies; freeze-drying alone does not prove lower impurities.
Depends on the dose, formulation and compression process.Tablet weightThe porous format can produce a light tablet. Confirm actual mass and batch consistency.
Depends on the ingredient dose and supporting materials.Ratio of excipients to active ingredientDepends on the matrix and ingredient dose. Development can target a lower proportion of excipients.
Depends on the excipients selected.Excipient solubilityWhether the matrix dissolves completely in water depends on its ingredients.
Depends on the drug and its route of absorption.First-pass metabolismBreakup in the mouth does not by itself establish mouth absorption or avoidance of first-pass metabolism.
Established for the specific drug and formulation.BioavailabilityAny improvement needs evidence for the specific product; it cannot be inferred from breakup speed.
Measured through pharmacokinetic studies of the finished product.Absorption rateRequires studies of the specific product. Fast disintegration does not necessarily mean faster absorption.
Depends on the medicine, dose and clinical evidence.Onset of actionRequires clinical evidence for the finished medicine. Rapid breakup is not a measure of treatment onset.

The BlinkTech technical presentation compares freeze-dried and compressed orally disintegrating tablets. To assess a particular product, start with the ingredient, dose, formulation and test method for each sample.

What happens in the mouth?
Compare tablet breakup time, mouthfeel and taste using the same protocol. A water demonstration gives a visual example of breakup.
How much ingredient is released?
Request dissolution or release measurements over time, content uniformity, tablet mass, particle size and the amounts of active and supporting ingredients.
What does the result establish?
Human studies of the finished product are needed to assess absorption, onset or changes in dose. For a probiotic, compare viable counts by strain, storage conditions and whether the blister was sealed or opened.

For each project, our team selects testing methods based on the intended market and product category.

Science and studies

What happens after a tablet breaks apart?

Different tests answer different questions: how a tablet breaks apart, how an ingredient dissolves or is absorbed, and how well living cultures survive storage.

Three questions about an oral dosage form
  1. 1. Does the tablet break up?

    Wetting and disintegration tests record how long the tablet takes to lose its structure under defined conditions.

  2. 2. Does the ingredient dissolve?

    Dissolution testing measures how much of the ingredient enters solution over time. The result depends on the ingredient and the test medium.

  3. 3. What reaches the bloodstream?

    For a drug, timed blood samples can establish peak concentration and overall exposure. Clinical effects require evidence for that drug and formulation.

SunTech schematic. The curve illustrates sampling over time and contains no patient measurements.

How to test probiotic survival after opening
Starting measurementCount viable organisms

Identify the strain and measure colony-forming units (CFU) per tablet from the same lot.

Sealed samples

Keep the original blister sealed at the specified temperature until each sampling time.

Opened samples

Record the opening time, exposure duration, temperature and humidity before sampling.

Compare like with likeMeasure retained CFU

Use the same assay and sampling times for both groups. Repeat with relevant lots and strains.

Proposed evaluation for a SunTech development project. Survival outside the pack would need to be demonstrated under the stated conditions.

What published research has measured

These independent studies evaluated their own formulations. They illustrate the kinds of questions a BlinkTech project can investigate.

Study findings

Formulation experiment

What changes disintegration time?

AlHusban and colleagues tested freeze-dried tablets made with different gelatin concentrations and gel strengths. Lower concentrations and lower gel strengths shortened breakup time in their formulations. Gelatin concentration also affected mechanical properties.

AlHusban et al., 2010 · Read study

Human crossover study

Does earlier detection mean greater exposure?

Markowitz and colleagues studied 5 mg olanzapine in 10 healthy volunteers. The disintegrating tablets produced more measurable early blood concentrations. Peak concentration, time to peak, and exposure over eight hours showed no statistically significant differences among the tested regimens.

Markowitz et al., 2006 · Read study

Probiotic storage study

What helps a dried culture stay viable?

Savini and colleagues compared protective ingredients in two freeze-dried Lactobacillus strains. At room temperature, glycerine preserved viability better than the other substances tested. Refrigerated samples showed no significant difference between the tested protectants and the milk control.

Savini et al., 2010 · Read study

Discuss a formulation or stability study →

Formulation feasibility

Start with the requirements that matter

Start with the ingredient, target dose and intended market. Then review taste, stability, packaging and production requirements with the SunTech team.

Formulation requirements and evaluation criteria

ConsiderationWhat to discussWhy it matters
Ingredient & doseIngredient identity, intended amount per tablet and combination ingredientsDefines the starting formulation and evaluation scope
Dispersion & fillingParticle size, solubility, suspension behavior and fill quantityInforms preparation and dose consistency
Taste & handlingTaste, mouthfeel, tablet dimensions and removal from the blisterShapes the intended user experience
Stability & packagingMoisture sensitivity, protective materials and intended storage conditionsDefines the evaluation needed for the finished product
Market & useDestination country, intended user, product category and labeling requirementsHelps establish the applicable project requirements

Suitability is evaluated for the proposed formulation, process and market.

Discuss feasibility →

Designed around the dose

Format and development considerations

1

Convenient individual doses

A portable format designed to be taken without water, with each dose protected until use.

2

Rapid disintegration

A porous structure helps the tablet break apart in the mouth. Confirm the disintegration specification for the finished formulation.

3

Integrated technology

Formulation systems and specialized equipment work together. Patent scope, technology rights and licensing terms are reviewed for each project.

4

Processing at low temperatures

Freezing and vacuum drying support development with ingredients that are sensitive to heat. Retained activity is verified through testing.

5

Ingredient release

The tablet structure helps release ingredients. Absorption and bioavailability need separate testing for the specific product.

6

Single ingredients or combinations

A tablet can contain one ingredient or several. The target dose must fit the tablet’s size, taste and manufacturing requirements.

7

Active ingredient loading and fewer fillers

For suitable formulations, development can target a high proportion of active pharmaceutical ingredient (API) with less supporting material, or excipient. The ratio depends on the formulation. Excipients are still needed for structure, taste and stability; this does not mean a higher prescribed dose.

8

Storage & shelf life planning

Protective packaging supports stability goals. Storage at room temperature and shelf life targets of up to 36 months must be supported by data from the finished product.

Animated demonstration of opening the tablet packet and removing the tablet

Opening the foil sleeve

How to release a tablet

The tablets come on a connected foil sleeve. Peel back the foil over one pocket to release a tablet. The other pockets stay sealed.

From preparation to packaging

Six stages, from ingredients to protective packaging

Each stage includes a short factory film and a photograph of the equipment.

Step 1 – Ultrafine grinding

Fine grinding prepares ingredients for even distribution. The technical presentation describes particles below 10 microns for selected ingredients.

Watch this stage 13 sec
Ultrafine grinding
Step 1 Ultrafine grinding

Step 2 – High-shear emulsification

Mixing at high speed helps create a uniform, stable suspension before filling.

Watch this stage 13 sec
High-speed shear emulsification
Step 2 High-shear emulsification

Step 3 – Precision filling

A precision pump dispenses measured amounts into individual cavities to support consistent tablet weight and ingredient content.

Watch this stage 15 sec
Precision filling
Step 3 Precision filling

Step 4 – Rapid freezing

Rapid freezing forms small ice crystals throughout the prepared formulation.

Watch this stage 15 sec
Rapid freezing
Step 4 Rapid freezing

Step 5 – Vacuum freeze-drying

Under vacuum, ice changes directly into vapor, leaving fine channels that create a porous tablet structure.

Watch this stage 18 sec
Vacuum drying
Step 5 Vacuum freeze-drying

Step 6 – Protective blister packaging

Coated aluminum blister materials help protect finished tablets from moisture and oxygen. Confirm barrier performance, seal integrity and compatibility for the product.

Watch this stage 16 sec
Protective blister packaging
Step 6 Protective blister packaging

Performance of the finished product

The details depend on your formulation

Can an existing pill be developed in this format?

Bring the active pharmaceutical ingredient (API), target dose and current product requirements to SunTech. A feasibility review determines whether a freeze-dried format can meet them. Compatibility cannot be assumed for every drug, particularly products that depend on a delayed or extended release profile.

Does rapid disintegration mean faster absorption?

Disintegration describes a tablet breaking apart. Absorption concerns how an ingredient enters the body. A disintegration demonstration alone cannot establish absorption, bioavailability or a health benefit.

How quickly does a tablet disintegrate?

Disintegration time depends on the ingredients, tablet structure and test conditions. Ask for the specification and supporting results for the product you are evaluating.

What determines stability and shelf life?

Ingredients, moisture protection, packaging and storage conditions all matter. Shelf life and handling instructions must be established for the finished formulation.

Which technical documents can I request?

Discuss the product specification, ingredient and strain information, stability or disintegration data, and available quality or batch documentation with SunTech. The applicable documents depend on the product and project.

Brochures & technical inquiries

Find the right information

These introductory guides summarize the platform and product presentation. Request specifications and test records for the product you need separately.

Get the SunTech Resource KitTechnical guides, partnership fliers, and QR codes to save or share.View downloads
PDF · 2 pages

SunTech capabilities overview

Four partnership options, six production stages and our manufacturing capacity.

Download capabilities PDF
PDF · 2 pages

Probiotic product guide

Why the tablet breaks apart in the mouth, what the format offers and who may prefer it.

Download probiotic guide PDF

Need specifications or quality documentation?

Tell us which product, market and documents you need. We will discuss the supporting information available for your inquiry.

Request technical information →

Assess your formulation

Send the ingredient, target dose and intended market.

Request a technical review →
TECHNOLOGY OVERVIEW

How BlinkTech freeze-dried tablets are made

Open video page

See how a porous tablet breaks apart without water, how SunTech develops formulations, and how six manufacturing stages turn a liquid into a sealed dose.

Video transcript

Conventional pharmaceutical tablets start as a powder that are pressed into a pill. The BlinkTech process starts with a liquid that is freeze dried and each dose sealed in a protective packet for enhanced viability.

Freeze-drying or Lyophilisation leaves tiny pores in the tablet. When a tablet is taken, saliva enters these pores allowing the tablet to be consumed without water.

Since the tablets do not require water or conventional swallowing, the tablets contain very little excipient filler compared to traditional pill dosage forms.

At SunTech, we start with your product and handle everything from tablet manufacturing to packaging, or enable our customers to create their own tablets.

Here's how we make the tablets. First, we prepare ingredients for tablet use by turning them into fine particles.

Next, we mix the ingredients evenly through the liquid. For an emulsion, the mixer breaks one liquid into tiny droplets that spread through the other.

Now we fill each dose into a tablet dosage tray.

We quickly freeze the filled trays, forming Ice crystals inside each dose. Their shape helps determine the pores left after drying.

Under vacuum, the ice turns directly into water vapor, this process is called sublimation. Where each crystal used to be, a tiny space is left behind.

Once the tablets are ready, we seal each pocket into is single dosage packaging to protect each single dose until usage. The challenge of working with a product as sensitive as probiotics forms an impressive use case for other ingredients and formulations from nutrients to medicines.

What would you like to make? SunTech can make it happen.

Watch another film